MRK
Merck & Co Inc
$135.50
2.63 (1.98%) Today
0.03 (0.02%) After-hours
— up— down
Market Cap
$327.94B+63.9%
Revenue (TTM)
$66.56B+4.6%
Net Income (TTM)
$3.09B-80.7%
EPS (TTM)
1.25-80.7%
Shares Out
2.47B
2.47BP/E Ratio
103.86
103.86Forward P/E
19.50
19.50Dividend
$3.27 (2.56%)
$3.27 (2.56%)Ex-Dividend Date
Jun 15, 2026
Jun 15, 2026Open
$133.86
$133.86Previous Close
$132.92
$132.92Day Range
$133.06 – $135.68
$133.06 – $135.6852-Week Range
$77.58 – $135.68
$77.58 – $135.68Beta
0.20
0.20Volume
6.91M
6.91MAvg Volume
9.87M
9.87MAnalyst Rating
Buy
BuyExchange
NEW YORK STOCK EXCHANGE, INC.
NEW YORK STOCK EXCHANGE, INC.About MRK
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue.
Related
News
N/AN/AN/AN/AN/A
Merck (MRK) Stock Looks Fully Valued Following Raised Revenue Outlook
Yahoo · 2h ago
Can Keytruda Sustain Merck's Growth in the Second Half of 2026?
Yahoo · 8h ago
Daiwa Capital Upgrades Merck (MRK)
Fintel · 16h ago
5 Insightful Analyst Questions From Merck’s Q2 Earnings Call
Yahoo · 22h ago
Here Are Wednesday’s Top Wall Street Analyst Research Calls: The Gap, Genmab, Hilton Worldwide, Intuitive Surgical, Marriott International, Merck, Novo Nordisk, Okta, and More
Yahoo · 1d ago